Hollencrest Capital Management’s Labcorp LH Stock Holding History

Hollencrest Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2	Closed	-$459	–	1158
2023 Q1	$459	Hold	2	–	–	﹤0.01%	1070
2022 Q4	$471	Buy	+2	New	+$391	﹤0.01%	1062

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Hollencrest Capital Management's LH Position: Q2 2023 in Review

Hollencrest Capital Management sold out of Labcorp (LH) in Q2 2023, closing a stake of 2 shares — an estimated $459 sold.

Hollencrest Capital Management first reported a position in LH in Q4 2022 and held it in 2 quarters. The position peaked at $471 in Q4 2022. 932 funds tracked by Wall St. Rank hold LH as of Q2 2023.

Hollencrest Capital Management reported no remaining Labcorp position as of Q2 2023 after selling out during the quarter.
Hollencrest Capital Management sold 2 Labcorp shares in Q2 2023, an estimated $459.
Hollencrest Capital Management first reported a position in Labcorp in Q4 2022 and held it in 2 quarters.
Hollencrest Capital Management's Labcorp position peaked at $471 in Q4 2022.
932 funds tracked by Wall St. Rank held Labcorp as of Q2 2023.

Based on Hollencrest Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.